Daiwa Securities Group Inc. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10
+25.0%
2320.0%0.00%
Q2 2023$8
-11.1%
2320.0%0.00%
Q1 2023$9
-18.2%
2320.0%0.00%
Q4 2022$11
-99.9%
232
+12.1%
0.00%
Q3 2022$14,0000.0%2070.0%0.00%
Q2 2022$14,000
+7.7%
207
+28.6%
0.00%
Q1 2022$13,000
-45.8%
1610.0%0.00%
Q4 2021$24,000
-22.6%
161
-9.0%
0.00%
Q3 2021$31,000
+93.8%
177
+77.0%
0.00%
Q2 2021$16,000
-5.9%
1000.0%0.00%
Q1 2021$17,000
-19.0%
100
+5.3%
0.00%
Q4 2020$21,000
-48.8%
95
-61.8%
0.00%
Q3 2020$41,000
+115.8%
249
+2.9%
0.00%
Q2 2020$19,0000.0%2420.0%0.00%
Q1 2020$19,000
-34.5%
242
+8.5%
0.00%
Q4 2019$29,000
+52.6%
223
-10.8%
0.00%
Q3 2019$19,000
-17.4%
250
+11.6%
0.00%
Q2 2019$23,000
+43.8%
2240.0%0.00%
Q1 2019$16,000
+45.5%
224
-14.5%
0.00%
Q4 2018$11,0002620.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders